SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients
Juan A Pérez-Bermejo; Serah S Kang; Sarah J. Rockwood; Camille R. Simoneau; David A Joy; Gokul N. Ramadoss; Ana C Silva; Will R. Flanigan; Huihui Li; Ken Nakamura; Jeffrey D. Whitman; Melanie Ott; Bruce R Conklin; Todd C McDevitt.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-265561
Although COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed productive infection and robust transcriptomic and morphological signatures of damage, particularly in cardiomyocytes. Transcriptomic disruption of structural proteins corroborated adverse morphologic features, which included a distinct pattern of myofibrillar fragmentation and numerous iPSC-cardiomyocytes lacking nuclear DNA. Human autopsy specimens from COVID-19 patients displayed similar sarcomeric disruption, as well as cardiomyocytes without DNA staining. These striking cytopathic features provide new insights into SARS-CoV-2 induced cardiac damage, offer a platform for discovery of potential therapeutics, and raise serious concerns about the long-term consequences of COVID-19.
Texto completo
Documentos relacionados